Literature DB >> 20645123

Erratum to: PEGylated PAMAM Dendrimer-Doxorubicin Conjugates: In Vitro Evaluation and In Vivo Tumor Accumulation.

Saijie Zhu1, Minghuang Hong, Lihong Zhang, Guotao Tang, Yanyan Jiang, Yuanying Pei.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20645123     DOI： 10.1007/s11095-010-0217-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  2 in total

1.  Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style.

Authors:  Saijie Zhu; Minghuang Hong; Guotao Tang; Lili Qian; Jiayuan Lin; Yanyan Jiang; Yuanying Pei
Journal:  Biomaterials       Date:  2009-11-02       Impact factor: 12.479

2.  PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation.

Authors:  Saijie Zhu; Minghuang Hong; Lihong Zhang; Guotao Tang; Yanyan Jiang; Yuanying Pei
Journal:  Pharm Res       Date:  2009-10-28       Impact factor: 4.200
  2 in total
  1 in total

1.  Transferrin Conjugated pH- and Redox-Responsive Poly(Amidoamine) Dendrimer Conjugate as an Efficient Drug Delivery Carrier for Cancer Therapy.

Authors:  Qing Hu; Yifei Wang; Lu Xu; Dawei Chen; Lifang Cheng
Journal:  Int J Nanomedicine       Date:  2020-04-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.